These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7101115)

  • 21. Carbapenems: monotherapy in intra-abdominal sepsis.
    Wilson SE
    Scand J Infect Dis Suppl; 1995; 96():28-33. PubMed ID: 7652500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
    Wilson SE; Faulkner K
    Am Surg; 1998 May; 64(5):402-7. PubMed ID: 9585772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection.
    Hopkins JA; Lee JC; Wilson SE
    Am Surg; 1993 Dec; 59(12):791-6. PubMed ID: 8256930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of oral antimicrobials for the management of intra-abdominal infections.
    Solomkin JS; Dellinger EP; Bohnen JM; Rostein OD
    New Horiz; 1998 May; 6(2 Suppl):S46-52. PubMed ID: 9654311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective double-blind controlled clinical study of sisomicin versus tobramycin.
    Schieker KR; Hofmann HF
    Pharmatherapeutica; 1981; 2(8):499-503. PubMed ID: 7019928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre comparison of clindamycin and metronidazole in the treatment of anaerobic infections.
    Collier J; Colhoun EM; Hill PL
    Scand J Infect Dis Suppl; 1981; 26():96-100. PubMed ID: 6941465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis.
    Mantzaris GJ; Hatzis A; Kontogiannis P; Triadaphyllou G
    Am J Gastroenterol; 1994 Jan; 89(1):43-6. PubMed ID: 8273796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial peritonitis. Protecting the high-risk patient.
    Jones LM; Miller S
    Am Surg; 1984 Jul; 50(7):358-61. PubMed ID: 6378000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.
    Solomkin J; Zhao YP; Ma EL; Chen MJ; Hampel B;
    Int J Antimicrob Agents; 2009 Nov; 34(5):439-45. PubMed ID: 19692210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
    Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous prophylactic antimicrobial drugs in elective colorectal operations.
    Bell GA; Fothergill J; Murphy J; Smith JA
    Surg Gynecol Obstet; 1983 Mar; 156(3):351-4. PubMed ID: 6828981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial.
    Orozco H; Arch J; Medina-Franco H; Pantoja JP; González QH; Vilatoba M; Hinojosa C; Vargas-Vorackova F; Sifuentes-Osornio J
    Arch Surg; 2006 Feb; 141(2):150-3; discussion 154. PubMed ID: 16490891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of use of parenteral metronidazole therapy in a teaching hospital.
    Jewesson PJ; Bachand RL; Bell GA; Ensom RJ; Chow AW
    Can Med Assoc J; 1985 Apr; 132(7):785-9. PubMed ID: 3978500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical therapeutic assessment of tobramycin (Nebramycin factor 6).
    Limson BM; Hipolito EF; Piga SA; Aquino A
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):19-23. PubMed ID: 821701
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tobramycin--clinical pharmacology and chemotherapy].
    Periti P
    J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis: ertapenem for complicated intra-abdominal infections.
    Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
    Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cephalothin-tobramycin as a preventive antibiotic combination.
    Crenshaw CA; Glanges E; Webber CE; Derrick HC; Turner RJ; Terrell CJ
    Surg Gynecol Obstet; 1978 Nov; 147(5):713-6. PubMed ID: 715648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.